Specifically, WHI found there was a 54 percent increased risk of death after a colorectal cancer diagnosis when female patients were randomized to combined hormone therapy compared to placebo trials. Although a few number of colorectal cancers resulted from the combined-therapy group, the group was at higher risk of mortality.
Read the abstract on menopausal hormone therapy and CRC.
Read other coverage about colorectal cancer:
– Studies Show Mailed and Electronic Reminders Increase Colorectal Cancer Screening Rates
– Study Suggests Hormone Therapy Could Increase Risk of CRC by Up To 40%
– 10 Recent Studies and Breakthroughs Impacting Gastroenterology/Endoscopy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
